Hyperketonemia increases monocyte adhesion to endothelial cells and is mediated by lfa-1 expression in monocytes and icam-1 expression in endothelial cells

American Journal of Physiology - Endocrinology and Metabolism

Volumn 301, Issue 2, 2011, Pages

  Rains, Justin L ^a   Jain, Sushil K ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Adhesion molecules; Inflammation; Intercellular adhesion molecule 1; Ketosis; Lymphocyte function associated antigen 1; Type 1 diabetes

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; VASCULAR CELL ADHESION MOLECULE 1;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ARTICLE; CELL ADHESION; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETES MELLITUS; HUMAN; HUMAN CELL; HYPERKETONEMIA; IN VITRO STUDY; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR DISEASE;

CELL ADHESION; CHEMOKINES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC KETOACIDOSIS; ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MONOCYTES; U937 CELLS; UMBILICAL VEINS; VASCULITIS;

EID: 79960800423     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00038.2011     Document Type: Article

References (38)

1. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 23: 381-389, 2000.
2. Abdelmegeed MA, Carruthers NJ, Woodcroft KJ, Kim SK, Novak RF. Acetoacetate induces CYP2E1 protein and suppresses CYP2E1 mRNA in primary cultured rat hepatocytes. J Pharmacol Exp Ther 315: 203-213, 2005.
3. Abdelmegeed MA, Kim SK, Woodcroft KJ, Novak RF. Acetoacetate activation of extracellular signal-regulated kinase 1/2 and p38 mitogenactivated protein kinase in primary cultured rat hepatocytes: role of oxidative stress. J Pharmacol Exp Ther 310: 728-736, 2004.
4. Asai A, Okajima F, Nakagawa K, Ibusuki D, Tanimura K, Nakajima Y, Nagao M, Sudo M, Harada T, Miyazawa T, Oikawa S. Phosphatidylcholine hydroperoxide-induced THP-1 cell adhesion to intracellular adhesion molecule-1. J Lipid Res 50: 957-965, 2009.
5. Bainton DFML, Kishimoto TK, Springer TA. Leukocyte adhesion receptors are stored in peroxidase-negative granules of human neutrophils. J Exp Med 166: 1641-1653, 1987.
6. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394: 894-897, 1998.
7. Candiloros HMS, Zeghari N, Donner M, Drouin P, Ziegler O. Decreased erythrocyte membrane fluidity in poorly controlled IDDM. Influence of ketone bodies. Diabetes Care 18: 549-551, 1995.
8. Devaraj S, Cheung AT, Jialal I, Griffen SC, Nguyen D, Glaser N, Aoki T. Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes 56: 2790-2796, 2007.
9. Devaraj S, Glaser N, Griffen S, Wang-Polagruto J, Miguelino E, Jialal I. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 55: 774-779, 2006.
10. Fasching P, Veitl M, Rohac M, Streli C, Schneider B, Waldhausl W, Wagner OF. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81: 4313-4317, 1996.
11. Fogelstrand L, Hulthe J, Hultén LM, Wiklund O, Fagerberg B. Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance. Diabetologia 47: 1948-1952, 2004.
12. Fuller JH, Stevens LK, Wang SL. Risk factors for cardiovascular mortality and morbidity: the WHO multinational study of vascular disease in diabetes. Diabetologia 44: S54-S64, 2001.
13. Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27: 2292-2301, 2007.
14. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2: 275-281, 1998.
15. Hoffman WH, Cheng C, Passmore GG, Carroll JE, Hess D. Acetoacetate increases expression of intercellular adhesion molecule-1 (ICAM-1) in human brain microvascular endothelial cells. Neurosci Lett 334: 71-74, 2002.
16. Jain SK, Kannan K, Lim G. Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Radic Biol Med 25: 1083-1088, 1998.
17. Jain SK, Kannan K, Lim G, Matthews-Greer J, McVie R, Bocchini JA,Jr. Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes. Diabetes Care 26: 2139-2143, 2003.
18. Jain SK, Kannan K, Lim G, McVie R, Bocchini JA,Jr. Hyperketonemia increases tumor necrosis factor-(alpha) secretion in cultured U937 monocytes and type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency. Diabetes 51: 2287-2293, 2002.
19. Jain SK, McVie R. Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients. Diabetes 48: 1850-1855, 1999.
20. Jain SK, McVie R, Bocchini JA,Jr. Hyperketonemia (ketosis), oxidative stress and type 1 diabetes. Pathophysiology 13: 163-170, 2006.
21. Jain SK, Rains JL, Croad JL. High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes. Antioxidants Redox Signaling 9: 1581-1590, 2007.
22. Libby P. Inflammation in atherosclerosis. Nature 420: 868-874, 2002.
23. Liehn EA, Zernecke A, Postea O, Weber C. Chemokines: inflammatory mediators of atherosclerosis. Arch Physiol Biochem 112: 229-238, 2006.
24. Lori L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 15: 412-426, 1999.
25. Miller LJ, Bainton DF, Borregaard N, Springer TA. Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface. J Clin Invest 80: 535-544, 1987.
26. Mysliwiec J, Kretowski A, Kinalski M, Kinalska I. CD11a expression and soluble ICAM-1 levels in peripheral blood in high-risk and overt type 1 diabetes subjects. Immunol Lett 70: 69-72, 1999.
27. Newton CA, Raskin P. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences. Arch Intern Med 164: 1925-1931, 2004.
28. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ. The 30-year natural history of type 1 diabetes complications. Diabetes 55: 1463-1469, 2006.
29. Papadopoulou C, Corrigall V, Taylor PR, Poston RN. The role of the chemokines MCP-1, GRO-[alpha], IL-8 and their receptors in the adhesion of monocytic cells to human atherosclerotic plaques. Cytokine 43: 181-186, 2008.
30. Pelletier A, Coderre L. Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation inadult cardiomyocytes. Am J Physiol Endocrinol Metab 292: E1325- E1332, 2007.
31. Roe TF, Crawford TO, Huff KR, Costin G, Kaufman FR, Nelson JMD. Brain infarction in children with diabetic ketoacidosis. J Diabet Complic 10: 100-108,.
32. Simon SI, Green CE. Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Annu Rev Biomed Eng 7: 151-152, 2005.
33. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K. Diabetes Care 29: 798-804, 2006.
34. Stephens JM, Sulway MJ, Watkins PJ. Relationship of blood acetoacetate and 3-hydroxybutyrate in diabetes. Diabetes 20: 485-489, 1971.
35. Umpierrez G, Kitabchi A. Diabetic ketoacidosis: risk factors and management strategies. Treatments Endocrinol 2: 95-108, 2003.
36. White NH. Diabetic ketoacidosis in children. Endocrinol Metab Clin North Am 29: 657-682, 2000.
37. White NH. Management of diabetic ketoacidosis. Rev Endocr Metab Dis 4: 343-353, 2003.
38. Yared Z, Chiasson J. Ketoacidosis and the hyperosmolar hyperglycemic state in adult diabetic patients. Diagnosis and treatment. Minervia Medica 94: 409-418, 2003.